Label Changes for:
Geodon (ziprasidone HCl) Capsules and Oral Suspension Geodon (ziprasidone mesylate) Injection
Changes have been made to the WARNINGS and PRECAUTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
WARNINGS AND PRECAUTIONS
- ...Long-standing hyperprolactinemia when associated with hypogonadism may lead to decreased bone density.